ACE inhibitor quinapril in the treatment of chronic cardiac failure

ACE inhibitor quinapril in the treatment of chronic cardiac failure

Aim. To assess effectiveness of A CE inhibitor quinapril in patients with moderate cardiac failure of ischemic etiology. Material and methods. 20 patients received quinapril in a daily dose 20 mgfor 6 months. Clinical condition, exercise tolerance, functional and geometric parameters of the left ven...

Full description

Bibliographic Details
Main Author:	A N Gadzhiev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2003-01-01
Series:	Терапевтический архив
Subjects:	chronic heart failure inhibitors of angiotensin convening enzyme left ventricle remodeling heart rhythm variability late potentials
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29292

Similar Items

Heart rate variability and structural and functional disorders of myocardium in patients with chronic prostatitis
by: D. N. Zaitsev, et al.
Published: (2013-04-01)

NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE
by: Reine Risa Risthanti, et al.
Published: (2017-08-01)

Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
by: Sheldon E. Litwin, et al.
Published: (2022-12-01)

LEFT VENTRICULAR REMODELING IN HEART FAILURE (PART I): CURRENT UNDERSTANDING OF PATHOMECHANISMS AND RELATED MYOCARDIAL DYSFUNCTION
by: T.Ya. Chursina, et al.
Published: (2022-08-01)

LEFT VENTRICULAR REMODELING IN HEART FAILURE (PART ІI): PHENOTYPIC HETEROGENEITY AS A RATIONALE FOR PERSONALIZED PATIENTS` MANAGEMENT
by: T.Ya. Chursina, et al.
Published: (2023-08-01)

Clinical and Molecular Implications of Osteopontin in Heart Failure
by: Argen Mamazhakypov, et al.
Published: (2022-08-01)

Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study
by: Yue-Jin Yang, et al.
Published: (2016-01-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
by: Urszula Tyrankiewicz, et al.
Published: (2021-06-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN‐HF Registry
by: Janice Y. Chyou, et al.
Published: (2021-03-01)

Renal and Myocardial Histopathology and Morphometry in Rats with Adenine - Induced Chronic Renal Failure: Influence of Gum Acacia
by: Badreldin H. Ali, et al.
Published: (2014-08-01)

Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
by: Su Yeong Park, et al.
Published: (2023-09-01)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
by: A.S. Ryazanov, et al.
Published: (2023-04-01)

POST-MI REMODELING OF THE LEFT VENTRICLE REMODELING: A CARDIAC SURGEON’S STANDPOINT
by: Y. V. Belov, et al.
Published: (2002-10-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
by: Pankaj Puar, et al.
Published: (2023-06-01)

Comparative analysis of left ventricular strain parameters in patients with heart failure of ischemic and non-ischemic genesis
by: N. N. Ilov, et al.
Published: (2023-01-01)

IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS?
by: T. A. Kazakovtseva, et al.
Published: (2016-01-01)

Angiotensin‐Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC‐QIC Registry
by: Jesse E. Hansen, et al.
Published: (2020-05-01)

Left Ventricle Remodeling for Patients with Heart Failure and its Influence on Cardiac Performance
by: Durra A. Ahmed, et al.
Published: (2013-07-01)

Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
by: Hong-Mi Choi, et al.
Published: (2020-05-01)

Safety and efficacy of ARNI (valsartan/sacubitril) vs ACEI (enalapril) in acute heart failure – A prospective observational study
by: Tahir Saleem Bhat, et al.
Published: (2022-05-01)

Aspects of myocardial heterogeneity in assessment its remodeling
by: Elena N. Minina, et al.
Published: (2022-12-01)

Influence of Age, Heart Failure and ACE Inhibitor Treatment on Plasma Renin Activity in Children: Insights from a Systematic Review and the European LENA Project
by: Melina Steichert, et al.
Published: (2023-12-01)

Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
by: A. S Galyavich
Published: (2010-03-01)

Efficacy of moderate exercise training on heart rate variability and left ventricular remodeling after myocardial infarction
by: Mohamad El Bordy, et al.
Published: (2021-01-01)

Long‐term impact of angiotensin receptor‐neprilysin inhibitor based on short‐term treatment response in heart failure
by: Hyuk Kyoon Park, et al.
Published: (2023-12-01)

Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure
by: Carlsson Marcus, et al.
Published: (2012-07-01)

Use of the Left Ventricular Internal Dimension at End-Diastole and the E-Point Septal Separation Ratio in the Prediction of the Left Ventricular Systolic Function in Patients with Midrange and Reduced Ejection Fractions: A Pilot Study
by: Kahraman Cosansu, et al.
Published: (2019-10-01)

STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. PASHCHENKO, et al.
Published: (2018-10-01)

Angiotensin receptor blockers in heart failure after the ELITE II trial
by: Willenheimer Ronnie
Published: (2000-09-01)

Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction
by: Sabina Andreea Leancă, et al.
Published: (2023-04-01)

Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01)

Do We Need to Know the Left Ventricular Geometry Patterns of the Brazilian Population?
by: Roberto M. Saraiva
Published: (2020-02-01)

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome
by: Ram B. Singh, et al.
Published: (2018-07-01)

Age-related Ventricular Remodeling is an Independent Risk for Heart Failure Symptoms in Subjects With Preserved Systolic Function
by: Chung-Lieh Hung, et al.
Published: (2011-03-01)

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
by: Yuxi Sun, et al.
Published: (2022-02-01)

Do cardiologists at a university hospital adopt the guidelines for the treatment of heart failure?
by: Antonio Carlos Pereira Barretto, et al.
Published: (2001-07-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)